Abstract:The mammalian olfactory system enables to sense and distinguish a large number of odors, which is essential to find food, avoid predators, communicate and reproduce, while the human olfactory system can even avoid potential hazard by discriminating the smell quality. Olfactory dysfunction is a common disease symptom which seriously affects the life quality of patients. In addition, many studies have revealed that olfactory dysfunction can also indicate many other potential diseases, such as neurodegenerative diseases and mental diseases. Olfactory dysfunction is an early common symptom of a variety of diseases, such as inflammation, viral infection, neurodegenerative diseases, and the current epidemic of COVID-19. Researchers have indicated that some patients with certain diseases already have suffered from symptoms of olfactory dysfunction early in the clinic. For instance, one of the early clinical symptoms of SARS-CoV-2 virus infection is the loss of smell. Besides, patients suffered from Alzheimer's disease and Parkinson's disease usually have an increased threshold of olfactory perception and even endure anosmia. Therefore, research on early screening and diagnosis of dysosmia diseases on the basis of olfactory function detection is of great significance to control and slow the disease's progression and to improve the health of human body. At present, olfactory function detection technologies mainly contain olfactory neuropsychological testing, electrophysiological detection, olfaction system structure or functional imaging, etc. Although these technologies have played an important role in the study of dysosmia, there have been no standardized detection indicators established so far. Therefore, the establishment and improvement of early olfactory dysfunction disease diagnosis technology based on the detection of olfactory function requires a novel approach in principle and technology. By utilizing the bionic olfactory sensing technologies such as bioelectronic noses, the olfactory analog sensing system with high sensitivity, high specificity and short response time, and even simulating biological olfactory systems, can be expected to be realized. Based on the current understanding of the mechanism of olfactory dysfunction, our team is committed to breaking through the traditional odor-induced olfactory function detection method. By combining with the bionic olfactory perception technology, three original methods which include olfactory neural network chip, organoid chip and neural interactive olfaction detection technology have been proposed. These three technologies essentially construct and simulate the olfactory nervous system in vitro or in vivo, by means of the sensing technique to detect physiological signals changes that correspond with the alternations in the nervous system. However, the difficulties currently lie in how to determine the characteristic physiological signal, and how to establish the correlation between the characteristic signals and the degree of dysosmia for the ultimate goal of further screening the olfactory dysfunction related diseases through the detection parameters. The clarification of these difficulties and in-depth progress of research will promote the innovation and development of olfactory function detection technology, and provide reliable theoretical technical support and experimental basis. This review comprehensively interpreted the current research status of dysosmia diseases, as well as analyzed the principles of bionic olfactory perception technology and its research progress in the detection and diagnosis of dysosmia and related diseases. With the development of multidisciplinary intersection in the field of biomedical engineering, the transformation and application of cell network chips, organoid bionic chips and braincomputer interaction technology will promote the progress of bionic olfactory perception technology in the research of olfactory dysfunction diseases and the innovation of clinical diseases diagnosis. © 2021, Science Press. All right reserved.

Optical sensors of volatile organic compounds for non-invasive diagnosis of diseases

Biophotonics technologies for the detection of VOCs in healthcare applications: Are we there yet?

Advances in the Bioinspired Olfactory Sensing Technology for Screening of Olfactory Dysfunction

The Experimental Research on Mimetic Optical Artificial Nose Sensor System and Detection of Respiration Odor

A Hybrid Wireless Electrodeless QCM-D for the Discrimination of Volatile Organic Compounds

VOC DETECTIONS WITH OPTICAL SPECTROSCOPY

Paving the Way for a Green Transition in the Design of Sensors and Biosensors for the Detection of Volatile Organic Compounds (VOCs)

Recent Advances in Sensing Materials Targeting Clinical Volatile Organic Compound (VOC) Biomarkers: A Review

Carbon-based nanomaterials for the detection of volatile organic compounds: A review

Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation

Volatile Organic Compounds as Potential Biomarkers for Noninvasive Disease Detection by Nanosensors: A Comprehensive Review

Fiber optic volatile organic compound gas sensors: A review

Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis

Does the last 20 years paradigm of clinical research using volatile organic compounds to non-invasively diagnose cancer need to change? Challenges and future direction

Volatolomics in healthcare and its advanced detection technology

Smartphone-based Sensing System Using ZnO and Graphene Modified Electrodes for VOCs Detection.

Fate of Sniff-the-Diseases through Nanomaterials-supported Optical Biochip Sensors

Electronic Nose for the Detection and Discrimination of Volatile Organic Compounds: Application, Challenges, and Perspectives

Breakthroughs in the Design of Novel Carbon-Based Metal Oxides Nanocomposites for VOCs Gas Sensing

Progress in Research on VOC Molecule Recognition by Semiconductor Sensors